Key statistics
As of last trade, ESSA Pharma Inc (EPIX:NAQ) traded at 1.78, 27.16% above the 52 week low of 1.40 set on Nov 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.74 |
---|---|
High | 1.82 |
Low | 1.74 |
Bid | 1.78 |
Offer | 1.81 |
Previous close | 1.73 |
Average volume | 503.50k |
---|---|
Shares outstanding | 44.39m |
Free float | 43.38m |
P/E (TTM) | -- |
Market cap | 76.79m USD |
EPS (TTM) | -0.6257 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 14:49 GMT.
More ▼
- ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
- ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress
- ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference